Houston, TX (November 3, 2016) – The Eta Upsilon chapter of The Pi Kappa Alpha Fraternity will host their 2nd annual Homerun for the Heart event in Arlington, Texas, on Sunday, November 20, 2016. The event will serve as the commencement of homecoming week at University of Texas – Arlington, with proceeds benefiting Texas Heart Institute, the UT Arlington Emergency Assistance Fund and the Erica Hochmeister Memorial Scholarship.

The Pi Kappa Alpha fraternity set a goal of raising $15,000 for the Texas Heart Institute this year, with the Homerun for the Heart event playing an important role in helping them achieve their goal. Texas Heart Institute is honored to be a part of this special event, and is grateful for the hard work and dedication of the Pi Kappa Alpha fraternity!

Homerun for the Heart is open to the public with tickets sold at the door for $5 each. The event includes a home run derby competition for two age groups – kids up to 12 years of age, and a second division for 13 years of age and up – as well as a silent auction, food trucks and activities for everyone to enjoy. If you are in the Arlington area, please consider supporting this fun event, and be sure to stop by the Texas Heart Institute’s booth to learn more about heart health and how you can support cardiovascular research.

###About the Texas Heart InstituteTexas Heart Institute, founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education and improved patient care. Together with its clinical partner, CHI St. Luke’s Health – Baylor St. Luke’s Medical Center, it has been ranked among the top cardiovascular centers in the United States by U.S. News & World Report’s annual guide to “America’s Best Hospitals” for the past 25 years. More information about THI (@Texas_Heart) is available at www.texasheart.org. About the Cardiovascular Cell Therapy Research NetworkThe CCTRN is funded by the National Heart, Lung, and Blood Institute and includes key stem cell centers in the United States with expertise in conducting clinical trials that safely evaluate new treatments for cardiovascular diseases. These centers include the Texas Heart Institute, University of Florida at Gainesville, Minneapolis Heart Institute Foundation, Stanford University, University of Louisville, University of Miami, and the Vascular and Cardiac Center for Adult Stem Cell Therapy in Indianapolis, Indiana. Further information on the CCTRN is available at www.cctrn.org.